C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 9/24 (2006.01) A61K 38/47 (2006.01) C12N 15/62 (2006.01)
Patent
CA 2553955
Targeted acid alpha-glucosidase therapeutics that localize to the lysosome are provided. The targeted therapeutics include a therapeutic agent, GAA, and a targeting moiety that binds a receptor on an exterior surface of the cell, permitting proper subcellular localization of the targeted therapeutic upon internalization of the receptor. Nucleic acids, cells, and methods relating to the practice of the invention are also provided.
Cette invention concerne des agents thérapeutiques ciblés à base d'alpha-glucosidase acide qui sont localisés au niveau du lysosome. Ces agents thérapeutiques ciblés comprennent un agent thérapeutique, l'alpha-glucosidase acide, et une fraction de ciblage qui se lie à un récepteur sur une surface extérieure de la cellule, ce qui permet d'obtenir une localisation infracellulaire correcte de l'agent thérapeutique ciblé dès l'internalisation du récepteur. Cette invention concerne également des acides nucléiques, des cellules et des méthodes associés à la mise en oeuvre de cette invention.
Lebowitz Jonathan
Maga John
Biomarin Pharmaceutical Inc.
Fasken Martineau Dumoulin Llp
Zystor Therapeutics Inc.
LandOfFree
Acid alpha-glucosidase and fragments thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Acid alpha-glucosidase and fragments thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acid alpha-glucosidase and fragments thereof will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1933608